| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |